Fiduciary Alliance LLC Has $4.80 Million Holdings in SPDR S&P Biotech ETF $XBI

Fiduciary Alliance LLC grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,002.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,210 shares of the exchange traded fund’s stock after buying an additional 32,017 shares during the period. Fiduciary Alliance LLC owned approximately 0.05% of SPDR S&P Biotech ETF worth $4,804,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Avoro Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $256,053,000. Wells Fargo & Company MN grew its holdings in SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the period. OMERS ADMINISTRATION Corp grew its holdings in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after purchasing an additional 1,187,907 shares during the period. Morgan Stanley increased its stake in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares in the last quarter. Finally, Assetmark Inc. increased its stake in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.8%

Shares of NYSEARCA XBI opened at $149.71 on Thursday. The firm has a market capitalization of $9.55 billion, a P/E ratio of 11.47 and a beta of 0.85. The firm’s 50-day moving average price is $134.55 and its 200-day moving average price is $128.31. SPDR S&P Biotech ETF has a 1-year low of $82.04 and a 1-year high of $151.78.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.